APOC2 and liver disorder: Consistent with other studies, we demonstrated an increase in apoC2/C3 levels post-treatment in non-cirrhotic patients irrespective of ribavirin exposure and provide further evidence that more advanced liver disease is associated with low levels of these apolipoproteins pre- and post-treatment (Table 2, Figure 4D,E).